Hypothalamic-Pituitary Brain Tumor Clinical Trials

Image of Marshfield Clinical Research Institute in Marshfield, United States.

Setmelanotide for Obesity

Any Age
All Sexes
Marshfield, WI
"This trial is looking at how safe and well-tolerated it is to continue giving setmelanotide to male and female patients over 2 years old who have rare genetic, syndromic,
Phase 3
Waitlist Available
Has No Placebo
Marshfield Clinical Research Institute (+12 Sites)David Meeker, MDRhythm Pharmaceuticals, Inc.
Image of Children's Hospital Colorado in Aurora, United States.

MEKTOVI for Pediatric Craniopharyngioma

1 - 25
All Sexes
Aurora, CO
This trial tests MEKTOVI, a pill that targets cancer growth proteins, in children and young adults with a recurring brain tumor called Adamantinomatous Craniopharyngioma. The drug works by blocking signals that make cancer cells grow.
Phase 2
Recruiting
Has No Placebo
Children's Hospital Colorado (+15 Sites)Maryam Fouladi, MD
Image of Children's Hospital Colorado in Aurora, United States.

ACTEMRA for Pediatric Craniopharyngioma

1 - 39
All Sexes
Aurora, CO
This trial tests ACTEMRA, a drug that blocks a protein called IL-6, in children with a recurring brain tumor called ACP. The goal is to see if it can reduce tumor growth and improve their quality of life.
Phase 2
Recruiting
Has No Placebo
Children's Hospital Colorado (+14 Sites)Maryam Fouladi, MD
View More